Marianne Schwartz
Research Subjects
Marianne Schwartz has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Flemming Skovby
Department of Clinical Genetics, The Juliane Marie Centre, Rigshospitalet, University Hospital, and 2Department of Clinical Biochemistry, Statens Serum Institut, Copenhagen; 3Department of Pediatrics, University of Colorado School of Medicine, Denver; and 4Department of Paediatrics, Næstved Hospital, Næstved, Denmark
3 shared publicationsJohn Vissing
3 shared publicationsKirstine Ravn
Department of Clinical Genetics, University Hospital, Rigshospitalet, Copenhagen, Denmark
2 shared publicationsThomas Rosenberg
2 shared publications- Allan Meldgaard Lund
Centre for Inherited Metabolic Diseases, Rigshospitalet Copenhagen Denmark
1 shared publication Ernst Christensen
Department of Clinical Genetics, The Juliane Marie Centre, Rigshospitalet, University Hospital, and 2Department of Clinical Biochemistry, Statens Serum Institut, Copenhagen; 3Department of Pediatrics, University of Colorado School of Medicine, Denver; and 4Department of Paediatrics, Næstved Hospital, Næstved, Denmark
1 shared publication
Latest Publications
- 17 October 2007
- Vol. 13, 1962-9
N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population.
The study was conducted to resolve the spectrum of ABCA4 mutations in a cohort of unrelated Danish residents with early-onset macular dystrophy. A microarray technique was used to analyze known ABCA4 mutations in genomic DNA from a selected group of 161 unrelated individuals referred to the national low vision clinic. The clinical observation time varied from a single examination to follow-up over 35 years. Fifty-nine allegedly disease-associated ABCA4 variants were found in 197 alleles (61.2%) from 124 (77.0%) patients. Two or three mutations were present in 73 (45.3%) patients, and only one mutation was found in 51 (31.7%) patients. The mutation spectrum included 45 missense mutations, five nonsense mutations, two frame shift deletions, and seven splice site mutations. The relative frequency among the mutations varied considerably. Twenty-eight mutations occurred only once among 197 alleles, while the five most abundant mutations were encountered in 50% of the mutation-carrying alleles. The rate of mutation detection, assessed as the fraction of individuals carrying at least one ABCA4 mutation, varied from 27% to 90% among seven phenotypic groups, and a single mutation, p.N965S (c.2894A>G) in the first nucleotide-binding domain accounted for 16.2% of 197 disease-associated alleles. The mutation causes moderate to serious phenotypes and eventually blindness. Our study is the first mutation analysis of Stargardt-related retinopathies in a large cohort of patients from a Scandinavian population. The mutation detection rate, performed with an array-based technique, was comparable to that of other microarray-based ABCA4 studies as well as studies using more laborious techniques involving screening methods followed by sequencing. Four out of five of the most prevalent ABCA4 mutations are reported to be frequent in other Western European populations as well. However, the prevalence of the most common Danish mutation, N965S, significantly deviates from the one found in other studies. This underscores that the ABCA4 mutation spectrum within relatively stable populations might be skewed due to founder effects. The clinical spectrum of patients, who are either homozygous or compound heterozygous for the N965S mutation, indicates that this mutation has an early and profound effect on retinal function.
- 17 October 2007
- Vol. 13, 1962-9
N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population.
The study was conducted to resolve the spectrum of ABCA4 mutations in a cohort of unrelated Danish residents with early-onset macular dystrophy. A microarray technique was used to analyze known ABCA4 mutations in genomic DNA from a selected group of 161 unrelated individuals referred to the national low vision clinic. The clinical observation time varied from a single examination to follow-up over 35 years. Fifty-nine allegedly disease-associated ABCA4 variants were found in 197 alleles (61.2%) from 124 (77.0%) patients. Two or three mutations were present in 73 (45.3%) patients, and only one mutation was found in 51 (31.7%) patients. The mutation spectrum included 45 missense mutations, five nonsense mutations, two frame shift deletions, and seven splice site mutations. The relative frequency among the mutations varied considerably. Twenty-eight mutations occurred only once among 197 alleles, while the five most abundant mutations were encountered in 50% of the mutation-carrying alleles. The rate of mutation detection, assessed as the fraction of individuals carrying at least one ABCA4 mutation, varied from 27% to 90% among seven phenotypic groups, and a single mutation, p.N965S (c.2894A>G) in the first nucleotide-binding domain accounted for 16.2% of 197 disease-associated alleles. The mutation causes moderate to serious phenotypes and eventually blindness. Our study is the first mutation analysis of Stargardt-related retinopathies in a large cohort of patients from a Scandinavian population. The mutation detection rate, performed with an array-based technique, was comparable to that of other microarray-based ABCA4 studies as well as studies using more laborious techniques involving screening methods followed by sequencing. Four out of five of the most prevalent ABCA4 mutations are reported to be frequent in other Western European populations as well. However, the prevalence of the most common Danish mutation, N965S, significantly deviates from the one found in other studies. This underscores that the ABCA4 mutation spectrum within relatively stable populations might be skewed due to founder effects. The clinical spectrum of patients, who are either homozygous or compound heterozygous for the N965S mutation, indicates that this mutation has an early and profound effect on retinal function.
- 14 February 2005
- Vol. 167 (7) , 745-8
[The molecular-genetic background of spinal muscular atrophy. Diagnosis, prognosis and future treatment].
- 14 February 2005
- Vol. 167 (7) , 745-8
[The molecular-genetic background of spinal muscular atrophy. Diagnosis, prognosis and future treatment].
- 7 December 2004
- Published by Wiley in Clinical Genetics
- Vol. 67 (2) , 189-191
Multiplex ligation-dependent probe amplification is superior for detecting deletions/duplications in Duchenne muscular dystrophy
- 7 December 2004
- Published by Wiley in Clinical Genetics
- Vol. 67 (2) , 189-191
Multiplex ligation-dependent probe amplification is superior for detecting deletions/duplications in Duchenne muscular dystrophy
- 1 December 2004
- Published by SAGE Publications in Genetic Testing
- Vol. 8 (4) , 361-367
Improved Molecular Diagnosis of Dystrophin Gene Mutations Using the Multiplex Ligation-Dependent Probe Amplification Method
Mutation detection in the DMD gene defective in Duchenne (DMD) and Becker muscular dystrophies (BMD) is complicated by the presence of 79 exons. The majority of recognized mutations are, however, copy number changes of individual exons, which traditionally have been identified by three common multiplex polymerase chain reaction (PCR) assays and/or Southern blotting. Here we report the use of the newly developed quantitative assay multiplex ligation-dependent probe amplification (MLPA) to determine the copy number of each of the 79 DMD exons in 182 males and 14 carrier females referred to our diagnostic facility on the clinical suspicion of DMD or BMD. The MLPA method confirmed all previously recognized mutations and identified an additional 28, including four point mutations. Also, the assay reliably identified 7 carrier females, which are usually not easily recognized. In our hands the method is highly reproducible, easy to handle, and has increased our mutation pick-up rate by a total of 33)%.
- 1 December 2004
- Published by SAGE Publications in Genetic Testing
- Vol. 8 (4) , 361-367
Improved Molecular Diagnosis of Dystrophin Gene Mutations Using the Multiplex Ligation-Dependent Probe Amplification Method
Mutation detection in the DMD gene defective in Duchenne (DMD) and Becker muscular dystrophies (BMD) is complicated by the presence of 79 exons. The majority of recognized mutations are, however, copy number changes of individual exons, which traditionally have been identified by three common multiplex polymerase chain reaction (PCR) assays and/or Southern blotting. Here we report the use of the newly developed quantitative assay multiplex ligation-dependent probe amplification (MLPA) to determine the copy number of each of the 79 DMD exons in 182 males and 14 carrier females referred to our diagnostic facility on the clinical suspicion of DMD or BMD. The MLPA method confirmed all previously recognized mutations and identified an additional 28, including four point mutations. Also, the assay reliably identified 7 carrier females, which are usually not easily recognized. In our hands the method is highly reproducible, easy to handle, and has increased our mutation pick-up rate by a total of 33)%.
- 1 March 2004
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2) , 99-101
No evidence for paternal inheritance of mtDNA in patients with sporadic mtDNA mutations
- 1 March 2004
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2) , 99-101
No evidence for paternal inheritance of mtDNA in patients with sporadic mtDNA mutations
- 17 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (2) , 247-251
New patterns of inheritance in mitochondrial disease
- 17 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (2) , 247-251
New patterns of inheritance in mitochondrial disease
- Open Access
- 22 August 2002
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (8) , 576-580
Paternal Inheritance of Mitochondrial DNA
Mammalian mitochondrial DNA (mtDNA) is thought to be strictly maternally inherited.1,2 Sperm mitochondria disappear in early embryogenesis by selective destruction, inactivation, or simple dilution by the vast surplus of oocyte mitochondria.3
- 22 August 2002
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (8) , 576-580
Open AccessPaternal Inheritance of Mitochondrial DNA
Mammalian mitochondrial DNA (mtDNA) is thought to be strictly maternally inherited.1,2 Sperm mitochondria disappear in early embryogenesis by selective destruction, inactivation, or simple dilution by the vast surplus of oocyte mitochondria.3
- 19 October 2001
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 9 (10) , 805-809
An mtDNA mutation, 14453G→A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome
The European Journal of Human Genetics is the official Journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports, News and Commentary articles and reviews in the rapidly expanding field of human genetics and genomics.
- 19 October 2001
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 9 (10) , 805-809
An mtDNA mutation, 14453G→A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome
The European Journal of Human Genetics is the official Journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports, News and Commentary articles and reviews in the rapidly expanding field of human genetics and genomics.
- 1 July 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 67 (1) , 203-206
High Incidence of Propionic Acidemia in Greenland Is Due to a Prevalent Mutation, 1540insCCC, in the Gene for the β-Subunit of Propionyl CoA Carboxylase
- 1 July 2000
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 67 (1) , 203-206
High Incidence of Propionic Acidemia in Greenland Is Due to a Prevalent Mutation, 1540insCCC, in the Gene for the β-Subunit of Propionyl CoA Carboxylase